Something to be done: Treating HIV/AIDS

Largely because of disparities in access to drug treatment and care, AIDS m orbidity and mortality have fallen in the developed world but continue to r ise among developing countries. Achieving more equitable access to AIDS dru gs is hindered by high drug prices, technical complexities related to the p rovision of health care, and conflict among stakeholders. Recognition that health is vital to the prospects of the emerging global society must be com bined with new mechanisms to help all stakeholders work together cooperativ ely. Tiered drugs pricing should be coupled with investment in health servi ces. An independent "Global Task Force," able to act as an "active think ta nk," could build consensus about the way forward.